Filing Details
STANDARD BIOTOOLS INC. (NASDAQ:LAB) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event.
8k filedNASDAQ:LAB
STANDARD BIOTOOLS INC. (LAB) Reports Material Event to SEC
Filing Details STANDARD BIOTOOLS INC. (NASDAQ:LAB) filed a Form 8-K with the Securities and Exchange Commission on July 28, 2026, disclosing a material event. Market Context…
Market Context
STANDARD BIOTOOLS INC.'s stock currently trades at $0.79 with a market capitalization of $567.2M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for STANDARD BIOTOOLS INC.'s stock.
All SEC filings for STANDARD BIOTOOLS INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View LAB Stock Page
Frequently Asked Questions
Where can I read LAB's SEC filings?
Browse all filings on our LAB SEC filings page.
What types of SEC filings does STANDARD BIOTOOLS INC. file?
Public companies like STANDARD BIOTOOLS INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.